As of 3:59pm ET
| +0.25 / +1.56%|
The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 30.00, with a high estimate of 39.00 and a low estimate of 8.00. The median estimate represents a +84.62% increase from the last price of 16.25.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.